

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.22906631 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.93002693 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.93002693 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.68980516 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.50139430 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.34796267 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.13209170 |
| 8 | cellular response to type I interferon (GO:0071357) | 5.13195114 |
| 9 | type I interferon signaling pathway (GO:0060337) | 5.13195114 |
| 10 | response to type I interferon (GO:0034340) | 5.11805804 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.03090530 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.77195555 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.77195555 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.77195555 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.77195555 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.77195555 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 4.77195555 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.59886361 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.59361507 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.25375399 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 4.19069257 |
| 22 | detection of other organism (GO:0098543) | 4.17151833 |
| 23 | negative regulation of T cell mediated immunity (GO:0002710) | 4.16095479 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 4.12006051 |
| 25 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.11250927 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.10255388 |
| 27 | detection of bacterium (GO:0016045) | 3.99888748 |
| 28 | T cell migration (GO:0072678) | 3.95907424 |
| 29 | negative T cell selection (GO:0043383) | 3.95770225 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.94149085 |
| 31 | negative thymic T cell selection (GO:0045060) | 3.93205629 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.87256866 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.86093638 |
| 34 | response to interleukin-15 (GO:0070672) | 3.77321965 |
| 35 | response to interferon-alpha (GO:0035455) | 3.77078335 |
| 36 | detection of molecule of bacterial origin (GO:0032490) | 3.70425890 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.67759653 |
| 38 | positive regulation of interferon-alpha production (GO:0032727) | 3.66666868 |
| 39 | response to peptidoglycan (GO:0032494) | 3.66209410 |
| 40 | microglial cell activation (GO:0001774) | 3.62983322 |
| 41 | cellular response to interleukin-15 (GO:0071350) | 3.61953748 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.60939466 |
| 43 | response to host immune response (GO:0052572) | 3.60939466 |
| 44 | regulation of interferon-alpha production (GO:0032647) | 3.58820594 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.51425879 |
| 46 | negative regulation of viral genome replication (GO:0045071) | 3.51208872 |
| 47 | leukocyte aggregation (GO:0070486) | 3.49872909 |
| 48 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.48321930 |
| 49 | positive thymic T cell selection (GO:0045059) | 3.46497832 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.46210092 |
| 51 | neutrophil activation involved in immune response (GO:0002283) | 3.44971357 |
| 52 | tolerance induction (GO:0002507) | 3.44663890 |
| 53 | regulation of T cell tolerance induction (GO:0002664) | 3.43135481 |
| 54 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.42570906 |
| 55 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.40335753 |
| 56 | response to interferon-beta (GO:0035456) | 3.39490743 |
| 57 | cellular extravasation (GO:0045123) | 3.36583858 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.36254454 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.36223130 |
| 60 | defense response to protozoan (GO:0042832) | 3.36133539 |
| 61 | regulation of regulatory T cell differentiation (GO:0045589) | 3.34631279 |
| 62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.32681376 |
| 63 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.32460170 |
| 64 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32351895 |
| 65 | response to host (GO:0075136) | 3.32351895 |
| 66 | response to host defenses (GO:0052200) | 3.32351895 |
| 67 | regulation of tolerance induction (GO:0002643) | 3.30693032 |
| 68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.29408433 |
| 69 | B cell mediated immunity (GO:0019724) | 3.28343430 |
| 70 | positive regulation of B cell differentiation (GO:0045579) | 3.26929845 |
| 71 | positive T cell selection (GO:0043368) | 3.22912141 |
| 72 | detection of biotic stimulus (GO:0009595) | 3.22341006 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 3.19123460 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 3.16669924 |
| 75 | T cell selection (GO:0045058) | 3.13038688 |
| 76 | interferon-gamma production (GO:0032609) | 3.12438539 |
| 77 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.10963901 |
| 78 | cellular response to interferon-gamma (GO:0071346) | 3.09353532 |
| 79 | activated T cell proliferation (GO:0050798) | 3.06203259 |
| 80 | macrophage activation (GO:0042116) | 3.05327856 |
| 81 | response to protozoan (GO:0001562) | 3.03285766 |
| 82 | negative regulation of innate immune response (GO:0045824) | 3.02554382 |
| 83 | positive regulation of tolerance induction (GO:0002645) | 3.02245300 |
| 84 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.00599684 |
| 85 | positive regulation of antigen processing and presentation (GO:0002579) | 2.98823482 |
| 86 | positive regulation of type 2 immune response (GO:0002830) | 2.98641096 |
| 87 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.97750553 |
| 88 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.96905088 |
| 89 | thymic T cell selection (GO:0045061) | 2.95950088 |
| 90 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.94079109 |
| 91 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.94057010 |
| 92 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94029582 |
| 93 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94029582 |
| 94 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93901469 |
| 95 | neutrophil activation (GO:0042119) | 2.91020542 |
| 96 | response to muramyl dipeptide (GO:0032495) | 2.90876671 |
| 97 | positive regulation of interferon-beta production (GO:0032728) | 2.90313036 |
| 98 | germinal center formation (GO:0002467) | 2.90070096 |
| 99 | cellular response to interferon-alpha (GO:0035457) | 2.87538521 |
| 100 | response to interferon-gamma (GO:0034341) | 2.86291581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.92594222 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.37939509 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.04521937 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.74801657 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.52713344 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.19106738 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.84758647 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.23720533 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.14097177 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.05844680 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.05756579 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.90424330 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.88406129 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.69345453 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41578403 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.38968842 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32588321 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.27679338 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.26863144 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17418747 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.12641546 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07829958 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.04273733 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.02574775 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.97133848 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93494257 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91565876 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89623989 |
| 29 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.88878154 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.88219843 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87445758 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87339354 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74644782 |
| 34 | GATA3_26560356_Chip-Seq_TH2_Human | 1.72888125 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61418330 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59946198 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58908543 |
| 38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49172957 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45243537 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.42270483 |
| 41 | * MAF_26560356_Chip-Seq_TH2_Human | 1.35087097 |
| 42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31768296 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.30753561 |
| 44 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30672207 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29400409 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27528358 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25660348 |
| 48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24778921 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22196218 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21510428 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21396710 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21362681 |
| 53 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20275223 |
| 54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19119685 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17679548 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14251777 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12092729 |
| 58 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11651224 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09313627 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08931886 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06504826 |
| 62 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05277038 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04937589 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04910900 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03607787 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00952305 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00895946 |
| 68 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00610367 |
| 69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.97361560 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95539347 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91760214 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91227045 |
| 73 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.89615567 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89458956 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89453706 |
| 76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87769143 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87586244 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87066142 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.87043617 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86984365 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82255423 |
| 82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.78310047 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76971072 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74547347 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.73684885 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.72974525 |
| 87 | GATA3_26560356_Chip-Seq_TH1_Human | 0.72944305 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72905246 |
| 89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.71612931 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.68063024 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.67884572 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.66144664 |
| 93 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.65449102 |
| 94 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.64529390 |
| 95 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.64406401 |
| 96 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.63783505 |
| 97 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.61311767 |
| 98 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59653054 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59462846 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58724353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.61785675 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.61090455 |
| 3 | MP0005671_abnormal_response_to | 3.67231988 |
| 4 | MP0003436_decreased_susceptibility_to | 3.51968784 |
| 5 | MP0003303_peritoneal_inflammation | 3.49876225 |
| 6 | MP0001800_abnormal_humoral_immune | 3.40607493 |
| 7 | MP0009785_altered_susceptibility_to | 3.28835151 |
| 8 | MP0000685_abnormal_immune_system | 3.24289010 |
| 9 | MP0001790_abnormal_immune_system | 3.23881646 |
| 10 | MP0005387_immune_system_phenotype | 3.23881646 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.13918998 |
| 12 | MP0005025_abnormal_response_to | 2.88116216 |
| 13 | MP0002723_abnormal_immune_serum | 2.85561030 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.82574711 |
| 15 | MP0006082_CNS_inflammation | 2.82424096 |
| 16 | MP0002419_abnormal_innate_immunity | 2.78671331 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.78050834 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.62152138 |
| 19 | MP0001819_abnormal_immune_cell | 2.60258094 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.60073467 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.34727748 |
| 22 | MP0002405_respiratory_system_inflammati | 2.04569720 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.03497102 |
| 24 | MP0002398_abnormal_bone_marrow | 2.02994875 |
| 25 | MP0000716_abnormal_immune_system | 2.02949278 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.94387505 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.89129730 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.84322065 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.81628338 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.72168950 |
| 31 | MP0004947_skin_inflammation | 1.70884688 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.69490109 |
| 33 | MP0009764_decreased_sensitivity_to | 1.67021985 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.65243610 |
| 35 | MP0002722_abnormal_immune_system | 1.60056190 |
| 36 | MP0003866_abnormal_defecation | 1.57635787 |
| 37 | MP0002429_abnormal_blood_cell | 1.56037878 |
| 38 | MP0008469_abnormal_protein_level | 1.53881694 |
| 39 | MP0005310_abnormal_salivary_gland | 1.53116315 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.47840759 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.46948832 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.46938558 |
| 43 | MP0002006_tumorigenesis | 1.36993060 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.32572670 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.31221958 |
| 46 | MP0001873_stomach_inflammation | 1.28597538 |
| 47 | MP0008260_abnormal_autophagy | 1.28073850 |
| 48 | MP0004883_abnormal_blood_vessel | 1.25311666 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.21994426 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.21477386 |
| 51 | MP0003828_pulmonary_edema | 1.19178440 |
| 52 | MP0000858_altered_metastatic_potential | 1.17215833 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.14679409 |
| 54 | MP0001853_heart_inflammation | 1.11441702 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.08186580 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.08186580 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.07536814 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.07229879 |
| 59 | MP0009278_abnormal_bone_marrow | 1.07196910 |
| 60 | MP0002933_joint_inflammation | 1.04123426 |
| 61 | MP0004381_abnormal_hair_follicle | 1.03903313 |
| 62 | MP0003045_fibrosis | 1.03629876 |
| 63 | MP0003448_altered_tumor_morphology | 1.03098580 |
| 64 | MP0001851_eye_inflammation | 1.00600567 |
| 65 | MP0002132_abnormal_respiratory_system | 0.99237766 |
| 66 | MP0005164_abnormal_response_to | 0.98902637 |
| 67 | MP0009763_increased_sensitivity_to | 0.98810603 |
| 68 | MP0004510_myositis | 0.97095254 |
| 69 | MP0003690_abnormal_glial_cell | 0.93730326 |
| 70 | MP0003075_altered_response_to | 0.92565062 |
| 71 | MP0005166_decreased_susceptibility_to | 0.89131476 |
| 72 | MP0001663_abnormal_digestive_system | 0.88074704 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 0.86856928 |
| 74 | MP0006054_spinal_hemorrhage | 0.81030458 |
| 75 | MP0000343_altered_response_to | 0.78685278 |
| 76 | MP0005390_skeleton_phenotype | 0.78277770 |
| 77 | MP0000604_amyloidosis | 0.77225580 |
| 78 | MP0000249_abnormal_blood_vessel | 0.75977028 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.75690276 |
| 80 | MP0002009_preneoplasia | 0.75362492 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.74606441 |
| 82 | MP0003091_abnormal_cell_migration | 0.73326771 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.71434612 |
| 84 | MP0005451_abnormal_body_composition | 0.70267138 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.70143033 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.70129146 |
| 87 | MP0005058_abnormal_lysosome_morphology | 0.66648564 |
| 88 | MP0003252_abnormal_bile_duct | 0.62619775 |
| 89 | MP0001958_emphysema | 0.61607644 |
| 90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59526299 |
| 91 | MP0008004_abnormal_stomach_pH | 0.59325403 |
| 92 | MP0000371_diluted_coat_color | 0.58904555 |
| 93 | MP0003795_abnormal_bone_structure | 0.57039163 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.53838447 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.53718073 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.53395237 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.52107633 |
| 98 | MP0008874_decreased_physiological_sensi | 0.50731881 |
| 99 | MP0004130_abnormal_muscle_cell | 0.50073014 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.48722361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.44950321 |
| 2 | Myositis (HP:0100614) | 5.21975773 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.20141890 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.18902235 |
| 5 | Optic neuritis (HP:0100653) | 5.18902235 |
| 6 | Orchitis (HP:0100796) | 5.07078772 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.94419649 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.70243331 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.67473380 |
| 10 | Recurrent cutaneous fungal infections (HP:0011370) | 4.63972567 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.63972567 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.63840987 |
| 13 | T lymphocytopenia (HP:0005403) | 4.60913107 |
| 14 | Abnormality of T cell number (HP:0011839) | 4.55506159 |
| 15 | Stomatitis (HP:0010280) | 4.50272423 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 4.17439867 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 4.11708323 |
| 18 | Meningitis (HP:0001287) | 4.11084181 |
| 19 | Vasculitis (HP:0002633) | 4.08678333 |
| 20 | Recurrent skin infections (HP:0001581) | 4.06808045 |
| 21 | Abnormality of macrophages (HP:0004311) | 4.06662879 |
| 22 | Recurrent viral infections (HP:0004429) | 3.88247113 |
| 23 | Encephalitis (HP:0002383) | 3.80136898 |
| 24 | Keratoconjunctivitis sicca (HP:0001097) | 3.70687466 |
| 25 | Recurrent bronchitis (HP:0002837) | 3.66764767 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66751381 |
| 27 | Abnormality of T cells (HP:0002843) | 3.66404514 |
| 28 | Hemoptysis (HP:0002105) | 3.59138627 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.58322378 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.49041826 |
| 31 | Panhypogammaglobulinemia (HP:0003139) | 3.36246019 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.28188152 |
| 33 | Obstructive lung disease (HP:0006536) | 3.27970865 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.27970865 |
| 35 | Agammaglobulinemia (HP:0004432) | 3.20997205 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 3.16661678 |
| 37 | Gingivitis (HP:0000230) | 3.14576134 |
| 38 | Increased IgM level (HP:0003496) | 3.12991920 |
| 39 | Leukocytosis (HP:0001974) | 3.07838943 |
| 40 | Chest pain (HP:0100749) | 3.03141402 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 3.00700743 |
| 42 | Chronic otitis media (HP:0000389) | 2.95721437 |
| 43 | Increased IgE level (HP:0003212) | 2.95687065 |
| 44 | Arterial thrombosis (HP:0004420) | 2.95243265 |
| 45 | IgG deficiency (HP:0004315) | 2.95180125 |
| 46 | Urticaria (HP:0001025) | 2.86705592 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.85022021 |
| 48 | Lymphopenia (HP:0001888) | 2.78031043 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.77310464 |
| 50 | Gastrointestinal stroma tumor (HP:0100723) | 2.76959238 |
| 51 | Eosinophilia (HP:0001880) | 2.74849860 |
| 52 | Colitis (HP:0002583) | 2.74296531 |
| 53 | Cellulitis (HP:0100658) | 2.73982389 |
| 54 | Pustule (HP:0200039) | 2.73025699 |
| 55 | Granulocytopenia (HP:0001913) | 2.71992979 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.69254643 |
| 57 | Pulmonary embolism (HP:0002204) | 2.69052544 |
| 58 | Gastrointestinal inflammation (HP:0004386) | 2.65969603 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.65349878 |
| 60 | Gingival bleeding (HP:0000225) | 2.63462248 |
| 61 | IgM deficiency (HP:0002850) | 2.60732177 |
| 62 | Peritonitis (HP:0002586) | 2.57585552 |
| 63 | Abnormality of eosinophils (HP:0001879) | 2.52940210 |
| 64 | Hypergammaglobulinemia (HP:0010702) | 2.52375386 |
| 65 | Gangrene (HP:0100758) | 2.52271925 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.52017097 |
| 67 | Recurrent sinusitis (HP:0011108) | 2.48423192 |
| 68 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.46304401 |
| 69 | Anorexia (HP:0002039) | 2.45304865 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.45208793 |
| 71 | Epistaxis (HP:0000421) | 2.40688330 |
| 72 | Stomach cancer (HP:0012126) | 2.36005914 |
| 73 | Chronic diarrhea (HP:0002028) | 2.34897634 |
| 74 | Osteomyelitis (HP:0002754) | 2.34381560 |
| 75 | B lymphocytopenia (HP:0010976) | 2.32650932 |
| 76 | Hypochromic anemia (HP:0001931) | 2.30835637 |
| 77 | Recurrent pneumonia (HP:0006532) | 2.26390210 |
| 78 | Abnormality of the peritoneum (HP:0002585) | 2.26274491 |
| 79 | Hematochezia (HP:0002573) | 2.23652535 |
| 80 | IgA deficiency (HP:0002720) | 2.22177804 |
| 81 | Severe combined immunodeficiency (HP:0004430) | 2.20453872 |
| 82 | Abnormality of the endocardium (HP:0004306) | 2.16766147 |
| 83 | Sepsis (HP:0100806) | 2.13508388 |
| 84 | Cheilitis (HP:0100825) | 2.11859725 |
| 85 | Acute hepatic failure (HP:0006554) | 2.11745356 |
| 86 | Hypochromic microcytic anemia (HP:0004840) | 2.08359919 |
| 87 | Chronic sinusitis (HP:0011109) | 2.07634432 |
| 88 | Emphysema (HP:0002097) | 2.06994875 |
| 89 | Skin rash (HP:0000988) | 2.06345070 |
| 90 | Skin ulcer (HP:0200042) | 2.06317793 |
| 91 | Abnormality of the prostate (HP:0008775) | 2.06013675 |
| 92 | Restrictive lung disease (HP:0002091) | 2.04961543 |
| 93 | Bronchitis (HP:0012387) | 2.04921890 |
| 94 | Keratitis (HP:0000491) | 2.04343366 |
| 95 | Recurrent lower respiratory tract infections (HP:0002783) | 2.04022045 |
| 96 | Joint swelling (HP:0001386) | 2.03526416 |
| 97 | Episodic fever (HP:0001954) | 2.02687799 |
| 98 | Papilloma (HP:0012740) | 2.01484694 |
| 99 | Verrucae (HP:0200043) | 2.01484694 |
| 100 | Viral hepatitis (HP:0006562) | 2.01011265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.15633077 |
| 2 | MAP4K1 | 4.03597760 |
| 3 | TYK2 | 3.45457190 |
| 4 | BLK | 3.05813004 |
| 5 | TXK | 2.97506734 |
| 6 | IKBKE | 2.91959389 |
| 7 | JAK3 | 2.75162853 |
| 8 | IRAK4 | 2.48837840 |
| 9 | JAK1 | 2.44806052 |
| 10 | MAP3K14 | 2.39499200 |
| 11 | CSK | 2.38378598 |
| 12 | KIT | 2.36689611 |
| 13 | FES | 2.16437267 |
| 14 | TAOK3 | 2.14471224 |
| 15 | SYK | 2.03909345 |
| 16 | BTK | 1.98398931 |
| 17 | MAP3K13 | 1.96073806 |
| 18 | TBK1 | 1.90805260 |
| 19 | ZAP70 | 1.83223234 |
| 20 | FGFR4 | 1.80067923 |
| 21 | MAP2K3 | 1.76199775 |
| 22 | ITK | 1.71932397 |
| 23 | TEC | 1.68530444 |
| 24 | GRK6 | 1.65655282 |
| 25 | PRPF4B | 1.62417557 |
| 26 | FGFR3 | 1.60132120 |
| 27 | HCK | 1.50524447 |
| 28 | TNK2 | 1.49940795 |
| 29 | ERN1 | 1.48265193 |
| 30 | LYN | 1.47023576 |
| 31 | BMPR2 | 1.42547500 |
| 32 | IKBKB | 1.41176565 |
| 33 | LCK | 1.41120149 |
| 34 | CSF1R | 1.37722003 |
| 35 | FRK | 1.35209996 |
| 36 | JAK2 | 1.32564913 |
| 37 | FGR | 1.30492804 |
| 38 | EPHB1 | 1.25222768 |
| 39 | IRAK1 | 1.23635647 |
| 40 | MATK | 1.12154315 |
| 41 | GRK7 | 1.07360802 |
| 42 | NLK | 1.06576895 |
| 43 | PIK3CG | 1.04139920 |
| 44 | MARK3 | 0.97807197 |
| 45 | TGFBR2 | 0.87293210 |
| 46 | EPHA3 | 0.84065503 |
| 47 | PRKCQ | 0.83107852 |
| 48 | MAP3K3 | 0.81609627 |
| 49 | SIK3 | 0.78385551 |
| 50 | CAMKK2 | 0.78137144 |
| 51 | MAP3K1 | 0.76609602 |
| 52 | CDC42BPA | 0.76392435 |
| 53 | MAPK7 | 0.75412583 |
| 54 | PTK2B | 0.73931617 |
| 55 | STK10 | 0.72764557 |
| 56 | SIK2 | 0.71592918 |
| 57 | HIPK2 | 0.70423617 |
| 58 | PDK1 | 0.70389986 |
| 59 | MAPK11 | 0.67864718 |
| 60 | ACVR1B | 0.67687618 |
| 61 | PIM1 | 0.67463273 |
| 62 | MAP3K11 | 0.64988682 |
| 63 | CHUK | 0.61355603 |
| 64 | NEK9 | 0.61290809 |
| 65 | MAP3K7 | 0.61204760 |
| 66 | TRPM7 | 0.58642489 |
| 67 | YES1 | 0.58218521 |
| 68 | ADRBK2 | 0.57502967 |
| 69 | MARK2 | 0.53755437 |
| 70 | MAP2K6 | 0.52903554 |
| 71 | TAOK1 | 0.52258397 |
| 72 | FYN | 0.51653781 |
| 73 | MAPK12 | 0.51164487 |
| 74 | MAP3K6 | 0.49018584 |
| 75 | IRAK2 | 0.48969834 |
| 76 | CDK19 | 0.46339726 |
| 77 | PRKD2 | 0.46047949 |
| 78 | KSR2 | 0.45509431 |
| 79 | SGK2 | 0.42466916 |
| 80 | MAP3K5 | 0.41967312 |
| 81 | CAMKK1 | 0.40682729 |
| 82 | PDPK1 | 0.38529887 |
| 83 | STK11 | 0.37275687 |
| 84 | ABL1 | 0.35146132 |
| 85 | CDK4 | 0.33452079 |
| 86 | MELK | 0.32530361 |
| 87 | PRKCH | 0.32367635 |
| 88 | WNK1 | 0.32357822 |
| 89 | TAOK2 | 0.32113950 |
| 90 | EGFR | 0.31894445 |
| 91 | SGK3 | 0.31714383 |
| 92 | LRRK2 | 0.30845882 |
| 93 | STK24 | 0.30240888 |
| 94 | PTK6 | 0.27865315 |
| 95 | CDK6 | 0.27608785 |
| 96 | MAPKAPK2 | 0.26552408 |
| 97 | PDGFRB | 0.26214490 |
| 98 | MOS | 0.26054605 |
| 99 | RPS6KA6 | 0.25923624 |
| 100 | MAP3K2 | 0.25264922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.33364446 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.20655123 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.12938755 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.96610110 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89339338 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.68114172 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.68042584 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.64760899 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46503456 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.45412780 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.44351017 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.22015647 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.21465288 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.19899530 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.13358620 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09292658 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.07394651 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05748189 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.90982883 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.89403798 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82499020 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.77842750 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76618558 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75121601 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.73227570 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65461464 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57192080 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.52998962 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51841003 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42158027 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41604930 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38709662 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34457989 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33953156 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.30036417 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.23438004 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.19328872 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16508857 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14984213 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14619768 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.14218577 |
| 42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04455731 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.03774673 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.01247670 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 0.96050242 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 0.83471309 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81504860 |
| 48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80915078 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79158832 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72389421 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70774991 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70704819 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68226237 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67783255 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63880740 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62069307 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.60382897 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.56642860 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55785657 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55016249 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.53115221 |
| 62 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52376306 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52288147 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51234426 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48743449 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48009388 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47709145 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47032054 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45191838 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43253140 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42262668 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41943172 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41840569 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38509254 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37062596 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.36461022 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35486473 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.35380364 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35295738 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34973238 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.33887606 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32469050 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32118657 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31335698 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29699781 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29058166 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28663917 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26710440 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26621539 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26163646 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25528839 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25365247 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.24659833 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24006625 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23506064 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23113657 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20027963 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.18665565 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.18525192 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18198582 |

